Level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca
Introduction: pharmacovigilance programs monitor the Adverse Drug Events (ADEs). Although Colombian legislation mandates healthcare service providers to have an institutional pharmacovigilance program, not all institutions comply with this regulation. Objective: Determine the level of implementation...
Uložené v:
| Vydané v: | Revista colombiana de ciencias químico-farmacéuticas Ročník 53; číslo 2; s. 488 - 512 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Bogota
Universidad Nacional de Colombia
06.06.2024
|
| Predmet: | |
| ISSN: | 0034-7418, 1909-6356 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Introduction: pharmacovigilance programs monitor the Adverse Drug Events (ADEs). Although Colombian legislation mandates healthcare service providers to have an institutional pharmacovigilance program, not all institutions comply with this regulation. Objective: Determine the level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca. Methodology: A survey was designed based on the HENRI PFv scale of the National Institute for Food and Drug Surveillance (INVIMA). The survey was sent to health institutions. Information was consulted in the special registry of health providers and information on the EAM report in VigiFlow. The association between the implementation of the program and each of the factors was evaluated, using Stata version 14 software. Results: 80 institutions participated, of which 81% were classified as being implemented and 19% as not being implemented. The item with the lowest compliance was having pharmacovigilance programs and strategies (40%) and having a quality management system (45%), and the item with the highest compliance was the review of alerts and health measures (88%). The bivariate analysis allowed establishing the association between program implementation and variables such as the presence of pharmaceutical personnel, the institution’s location in a large municipality, the program’s operational duration of more than one year, and the perception that INVIMA does not send reports to stakeholders. Conclusion: The implementation was determined for each institution. The factors associated with implementation constitute aspects to consider to improve the functioning of pharmacovigilance programs.
Introducción: Los Eventos Adversos Medicamentosos (EAM), son vigilados por los programas de farmacovigilancia. Aunque en Colombia la legislación exige a las instituciones prestadoras de servicios de salud contar con un programa institucional de farmacovigilancia, no todas las instituciones cumplen esta regulación. Objetivo: Determinar el nivel de implementación del programa de farmacovigilancia y sus factores asociados en instituciones de salud del Valle del Cauca. Metodología: Se diseñó una encuesta basada en la escala HENRI PFv del Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). La encuesta se envió a las instituciones de salud. Se consultó información en el registro especial de prestadores de salud e información sobre el reporte en VigiFlow. Resultados: Participaron 80 instituciones de las que el 81% catalogaron como en implementación y el 19% como no implementado. El ítem de menor cumplimiento fue contar con programas y estrategias de farmacovigilancia (40%) y contar con un sistema de gestión de calidad (45%) y el item de mayor cumplimiento fue la revisión de alertas y medidas sanitarias (88%). El análisis bivariado permitió establecer la asociación entre la implementación del programa y variables como la presencia de personal farmacéutico, la ubicación de la institución en un municipio grande, la duración del funcionamiento del programa de más de un año, y la percepción de que el INVIMA no envía reportes a los actores. Conclusión: Se determinó la implementación para cada institución. Los factores asociados a la implementación constituyen aspectos a considerar para mejorar el funcionamiento de los programas de farmacovigilancia.
Introdução: Os Eventos Adversos Medicamentosos (EAM), são vigiados pelos programas de farmacovigilância. Embora na Colômbia a legislação exija que as instituições prestadoras de serviços de saúde contem com um programa institucional de farmacovigilância, nem todas as instituições cumprem esta regulamentação. Objetivo: Determinar o nível de implementação do programa de farmacovigilância e seus fatores associados nas instituições de saúde do Vale do Cauca. Metodologia: Foi desenvolvida uma consulta baseada na escala HENRI PFv do Instituto Nacional de Vigilância de Medicamentos e Alimentos (INVIMA). A consulta foi enviada às instituições de saúde. Foram consultadas informações no registro especial de discussão de saúde e informações sobre o relatório no VigiFlow. Resultados: Participaram 80 instituições das quais 81% foram catalogadas como em implementação e 19% como não implantadas. O item de menor cumprimento foi contado com programas e estratégias de farmacovigilância (40%) e contado com um sistema de gestão de qualidade (45%) e o item de maior cumprimento foi a revisão de alertas e medidas sanitárias (88%). A análise bivariada permitiu estabelecer a associação entre a implementação do programa e variáveis como a presença de farmacêutico pessoal, a localização da instituição em um município grande, a duração do funcionamento do programa por mais de um ano, e a percepção de que o INVIMA no envía reporta aos atores. Conclusão: Foi determinada a implementação para cada instituição. Os fatores associados à implementação constituem aspectos a serem considerados para melhorar o funcionamento dos programas de farmacovigilância. |
|---|---|
| AbstractList | Introduction: pharmacovigilance programs monitor the Adverse Drug Events (ADEs). Although Colombian legislation mandates healthcare service providers to have an institutional pharmacovigilance program, not all institutions comply with this regulation. Objective: Determine the level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca. Methodology: A survey was designed based on the HENRI PFv scale of the National Institute for Food and Drug Surveillance (INVIMA). The survey was sent to health institutions. Information was consulted in the special registry of health providers and information on the EAM report in VigiFlow. The association between the implementation of the program and each of the factors was evaluated, using Stata version 14 software. Results: 80 institutions participated, of which 81% were classified as being implemented and 19% as not being implemented. The item with the lowest compliance was having pharmacovigilance programs and strategies (40%) and having a quality management system (45%), and the item with the highest compliance was the review of alerts and health measures (88%). The bivariate analysis allowed establishing the association between program implementation and variables such as the presence of pharmaceutical personnel, the institution’s location in a large municipality, the program’s operational duration of more than one year, and the perception that INVIMA does not send reports to stakeholders. Conclusion: The implementation was determined for each institution. The factors associated with implementation constitute aspects to consider to improve the functioning of pharmacovigilance programs. Introduction: pharmacovigilance programs monitor the Adverse Drug Events (ADEs). Although Colombian legislation mandates healthcare service providers to have an institutional pharmacovigilance program, not all institutions comply with this regulation. Objective: Determine the level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca. Methodology: A survey was designed based on the HENRI PFv scale of the National Institute for Food and Drug Surveillance (INVIMA). The survey was sent to health institutions. Information was consulted in the special registry of health providers and information on the EAM report in VigiFlow. The association between the implementation of the program and each of the factors was evaluated, using Stata version 14 software. Results: 80 institutions participated, of which 81% were classified as being implemented and 19% as not being implemented. The item with the lowest compliance was having pharmacovigilance programs and strategies (40%) and having a quality management system (45%), and the item with the highest compliance was the review of alerts and health measures (88%). The bivariate analysis allowed establishing the association between program implementation and variables such as the presence of pharmaceutical personnel, the institution’s location in a large municipality, the program’s operational duration of more than one year, and the perception that INVIMA does not send reports to stakeholders. Conclusion: The implementation was determined for each institution. The factors associated with implementation constitute aspects to consider to improve the functioning of pharmacovigilance programs. Introducción: Los Eventos Adversos Medicamentosos (EAM), son vigilados por los programas de farmacovigilancia. Aunque en Colombia la legislación exige a las instituciones prestadoras de servicios de salud contar con un programa institucional de farmacovigilancia, no todas las instituciones cumplen esta regulación. Objetivo: Determinar el nivel de implementación del programa de farmacovigilancia y sus factores asociados en instituciones de salud del Valle del Cauca. Metodología: Se diseñó una encuesta basada en la escala HENRI PFv del Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). La encuesta se envió a las instituciones de salud. Se consultó información en el registro especial de prestadores de salud e información sobre el reporte en VigiFlow. Resultados: Participaron 80 instituciones de las que el 81% catalogaron como en implementación y el 19% como no implementado. El ítem de menor cumplimiento fue contar con programas y estrategias de farmacovigilancia (40%) y contar con un sistema de gestión de calidad (45%) y el item de mayor cumplimiento fue la revisión de alertas y medidas sanitarias (88%). El análisis bivariado permitió establecer la asociación entre la implementación del programa y variables como la presencia de personal farmacéutico, la ubicación de la institución en un municipio grande, la duración del funcionamiento del programa de más de un año, y la percepción de que el INVIMA no envía reportes a los actores. Conclusión: Se determinó la implementación para cada institución. Los factores asociados a la implementación constituyen aspectos a considerar para mejorar el funcionamiento de los programas de farmacovigilancia. Introdução: Os Eventos Adversos Medicamentosos (EAM), são vigiados pelos programas de farmacovigilância. Embora na Colômbia a legislação exija que as instituições prestadoras de serviços de saúde contem com um programa institucional de farmacovigilância, nem todas as instituições cumprem esta regulamentação. Objetivo: Determinar o nível de implementação do programa de farmacovigilância e seus fatores associados nas instituições de saúde do Vale do Cauca. Metodologia: Foi desenvolvida uma consulta baseada na escala HENRI PFv do Instituto Nacional de Vigilância de Medicamentos e Alimentos (INVIMA). A consulta foi enviada às instituições de saúde. Foram consultadas informações no registro especial de discussão de saúde e informações sobre o relatório no VigiFlow. Resultados: Participaram 80 instituições das quais 81% foram catalogadas como em implementação e 19% como não implantadas. O item de menor cumprimento foi contado com programas e estratégias de farmacovigilância (40%) e contado com um sistema de gestão de qualidade (45%) e o item de maior cumprimento foi a revisão de alertas e medidas sanitárias (88%). A análise bivariada permitiu estabelecer a associação entre a implementação do programa e variáveis como a presença de farmacêutico pessoal, a localização da instituição em um município grande, a duração do funcionamento do programa por mais de um ano, e a percepção de que o INVIMA no envía reporta aos atores. Conclusão: Foi determinada a implementação para cada instituição. Os fatores associados à implementação constituem aspectos a serem considerados para melhorar o funcionamento dos programas de farmacovigilância. |
| Author | Castro Espinosa, Jobany Estupiñán Cabrera, Hernán Pino Quinto, Daihana Moreno Posso, Laura Valentina Donoso Huertas, María Cristina Gil Pineda, María Alejandra |
| Author_xml | – sequence: 1 givenname: Jobany orcidid: 0000-0002-3476-248X surname: Castro Espinosa fullname: Castro Espinosa, Jobany – sequence: 2 givenname: Hernán orcidid: 0009-0007-0391-8385 surname: Estupiñán Cabrera fullname: Estupiñán Cabrera, Hernán – sequence: 3 givenname: María Alejandra orcidid: 0009-0007-6470-4356 surname: Gil Pineda fullname: Gil Pineda, María Alejandra – sequence: 4 givenname: Laura Valentina surname: Moreno Posso fullname: Moreno Posso, Laura Valentina – sequence: 5 givenname: María Cristina surname: Donoso Huertas fullname: Donoso Huertas, María Cristina – sequence: 6 givenname: Daihana orcidid: 0009-0007-6302-6207 surname: Pino Quinto fullname: Pino Quinto, Daihana |
| BookMark | eNo9kEtLAzEUhYNUsGp_gwHXU5PJYyZLKb6g4EbdDreZpE2ZSdokU3Dhf3faindzL4fDOZfvGk188AahO0rmVHAuH6LWbj84C_ODYL6cU8q5YBdoShVRhWRCTtCUEMaLitP6Cs1S2pJxhOSU1lP0szQH0-Fgset3nemNz5Bd8EclbwzebSD2oMPBrV0HXo9KDOsIPQbfYpcThpSCdpBNiy3oHGLCzuONgS5vxitll4dj4kn-gq4zuB0bFzBouEWXFrpkZn_7Bn0-P30sXovl-8vb4nFZaKoEKzgQWQmtrQQARjQTpWAr3uqSyYqvWrsiqjRErbQqhS1VzepWWtJS3VptKWE36P6cOz6_H0zKzTYM0Y-VDSNKEKkYk6OrOrt0DClFY5tddD3E74aS5oS7-cfdnHA3Z9zsF-9pevU |
| Cites_doi | 10.1177/0018578719851455 10.3390/ph15030298 10.1016/j.jsps.2018.04.012 10.1016/j.jsps.2022.03.009 10.3390/ph15121536 10.1016/j.heliyon.2022.e09016 10.3126/nmcj.v21i1.24854 10.1017/S0266462313000457 10.26719/2021.27.7.693 10.1002/pds.4991 10.3390/ph15030286 10.1111/ijcp.14731 10.2165/11631940-000000000-00000 10.1007/s40290-020-00349-6 10.1093/jamia/ocx102 10.3390/ph15121455 10.3390/ph14050425 10.3390/ph15060675 10.1007/s43441-022-00415-y 10.3389/fphar.2021.789103 10.1093/ijpp/riab037 10.1177/009286150704100610 10.3390/ph14080783 10.1111/bcp.15193 10.1016/j.medcli.2019.08.007 10.3390/ph15091148 |
| ContentType | Journal Article |
| Copyright | 2024. This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024. This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION 3V. 7RV 7XB 8FE 8FG 8FI 8FJ 8FK 8G5 ABJCF ABUWG AFKRA AZQEC BENPR BGLVJ CCPQU CLZPN D1I DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ KB. KB0 M2O MBDVC NAPCQ PADUT PDBOC PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U |
| DOI | 10.15446/rcciquifa.v53n2.114453 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Technology Collection ProQuest One Latin America & Iberian Database ProQuest Materials Science Collection ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Materials Science Database Nursing & Allied Health Database (Alumni Edition) Proquest Research Library Research Library (Corporate) Nursing & Allied Health Premium Research Library China Materials Science Collection (ProQuest) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database (ProQuest) ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic |
| DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials Materials Science Collection ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection ProQuest Central Korea Materials Science Database ProQuest Research Library ProQuest Central (New) Research Library China ProQuest Materials Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium Latin America & Iberian Database ProQuest One Academic UKI Edition Materials Science & Engineering Collection ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1909-6356 |
| EndPage | 512 |
| ExternalDocumentID | 10_15446_rcciquifa_v53n2_114453 |
| GroupedDBID | 7RV 8FE 8FG 8FI 8FJ 8G5 AAYXX ABDBF ABJCF ABUWG ACIWK ACUHS AFFHD AFKRA ALMA_UNASSIGNED_HOLDINGS AZQEC BENPR BGLVJ BKEYQ BPHCQ BVXVI CCPQU CITATION CLZPN D1I DIK DWQXO FYUFA GNUQQ GUQSH HCIFZ KB. M2O NAPCQ OK1 PADUT PDBOC PHGZM PHGZT PIMPY PPXIY PQGLB PQQKQ PROAC UKHRP 3V. 7XB 8FK MBDVC PKEHL PQEST PQUKI PRINS Q9U |
| ID | FETCH-LOGICAL-c1953-4a0675ccf6aaa30c35253b4dc23674bdfb092e09bc925f29838d6f0d1cdfcf103 |
| IEDL.DBID | 7RV |
| ISSN | 0034-7418 |
| IngestDate | Mon Oct 13 19:10:30 EDT 2025 Sat Nov 29 06:13:14 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1953-4a0675ccf6aaa30c35253b4dc23674bdfb092e09bc925f29838d6f0d1cdfcf103 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| ORCID | 0000-0002-3476-248X 0009-0007-6470-4356 0009-0007-6302-6207 0009-0007-0391-8385 |
| OpenAccessLink | https://www.proquest.com/docview/3095069336?pq-origsite=%requestingapplication% |
| PQID | 3095069336 |
| PQPubID | 2035763 |
| PageCount | 25 |
| ParticipantIDs | proquest_journals_3095069336 crossref_primary_10_15446_rcciquifa_v53n2_114453 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-06 |
| PublicationDateYYYYMMDD | 2024-06-06 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | Bogota |
| PublicationPlace_xml | – name: Bogota |
| PublicationTitle | Revista colombiana de ciencias químico-farmacéuticas |
| PublicationYear | 2024 |
| Publisher | Universidad Nacional de Colombia |
| Publisher_xml | – name: Universidad Nacional de Colombia |
| References | 2340494 2340495 2340498 2340499 2340510 2340496 2340497 2340513 2340514 2340511 2340512 2340517 2340518 2340515 2340516 2340508 2340509 2340520 2340521 2340502 2340524 2340503 2340500 2340522 2340501 2340523 2340506 2340507 2340504 2340505 2340519 |
| References_xml | – ident: 2340511 doi: 10.1177/0018578719851455 – ident: 2340494 doi: 10.3390/ph15030298 – ident: 2340504 doi: 10.1016/j.jsps.2018.04.012 – ident: 2340507 doi: 10.1016/j.jsps.2022.03.009 – ident: 2340521 doi: 10.3390/ph15121536 – ident: 2340512 doi: 10.1016/j.heliyon.2022.e09016 – ident: 2340506 doi: 10.3126/nmcj.v21i1.24854 – ident: 2340519 doi: 10.1017/S0266462313000457 – ident: 2340510 doi: 10.26719/2021.27.7.693 – ident: 2340503 doi: 10.1002/pds.4991 – ident: 2340523 doi: 10.3390/ph15030286 – ident: 2340497 – ident: 2340505 doi: 10.1111/ijcp.14731 – ident: 2340501 doi: 10.2165/11631940-000000000-00000 – ident: 2340508 – ident: 2340502 doi: 10.1007/s40290-020-00349-6 – ident: 2340517 doi: 10.1093/jamia/ocx102 – ident: 2340522 doi: 10.3390/ph15121455 – ident: 2340524 doi: 10.3390/ph14050425 – ident: 2340520 doi: 10.3390/ph15060675 – ident: 2340499 doi: 10.1007/s43441-022-00415-y – ident: 2340500 doi: 10.3389/fphar.2021.789103 – ident: 2340509 doi: 10.1093/ijpp/riab037 – ident: 2340513 – ident: 2340516 doi: 10.1177/009286150704100610 – ident: 2340495 doi: 10.3390/ph14080783 – ident: 2340515 – ident: 2340514 doi: 10.1111/bcp.15193 – ident: 2340496 doi: 10.1016/j.medcli.2019.08.007 – ident: 2340518 doi: 10.3390/ph15091148 – ident: 2340498 |
| SSID | ssj0000564118 ssib040262412 |
| Score | 2.258035 |
| Snippet | Introduction: pharmacovigilance programs monitor the Adverse Drug Events (ADEs). Although Colombian legislation mandates healthcare service providers to have... |
| SourceID | proquest crossref |
| SourceType | Aggregation Database Index Database |
| StartPage | 488 |
| SubjectTerms | Bivariate analysis Health services Legislation Pharmacovigilance Quality management |
| Title | Level of implementation of the pharmacovigilance program and its associated factors in health institutions in Valle del Cauca |
| URI | https://www.proquest.com/docview/3095069336 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Latin America & Iberia Database customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: CLZPN dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.proquest.com/latinamericaiberian providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: KB. dateStart: 20040101 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: 7RV dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: BENPR dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: M2O dateStart: 20040101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1909-6356 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000564118 issn: 0034-7418 databaseCode: PIMPY dateStart: 20040101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT6wwFG58Ldz4uF5zfaaLG1eiBUopK6NGo1FHYtR4V6S09IZEmXGYmcSF_91zoDhx48YNgQMBku_0PNrT7xDyN5ZKqlhyz8SF8bgS2stF4nsit0zGOgaXz5pmE3GvJ5-ektRNuNWurLKziY2hNn2Nc-SHIcQCTED6LY4Grx52jcLVVddCY5bM--i7QZ_ju8dOnyA1EgF37rvl-hbc91vjHHIPiVtcyVcEWdHhUOvydVxadTCJwipAGl0ehV8d1ld73Tih8-Wf_v4KWXLhJz1u9WWVzBTVL7KXtvzVb_v0frodq96nezSdMlu_rZH3aywxon1Ly5eu7hyBRQkEknTgnp6U_8tnVCfqyr-oqgwtRzVVThsKQ12nH1pWtN2MCWdt4QKOBBQ_Yp8XauCLp2qs1W_ycH52f3rhuf4NnsbFOUAe0xGtrVBKhUwj82qYc6ORNY7nxuYsCQqW5DoJIhskMpRGWGZ8bay2PgvXyVzVr4o_hIoc4jjOrYHok0c5k4mvYgUvMlYaULYNwjqQskFL05FheoO4Zp-4Zg2uWYvrBtnukMrcuK2zKUyb39_eIosBhDdN0ZjYJnOj4bjYIQt6Mirr4W6jhrtk_uSsl97B1dXJARxvgluQpZc36b8PxWLstA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VLRJc-EYUWvABemqokziOc6hQVai66naVw4LKKTh2jCJBdrvZXbQH_hK_sZ7YYdULtx64RU7kRM4bzxt7_AbgbSqkkKlggU4rHTDJVVDyLAx4aahIVWpdPu2KTaTjsbi8zPIt-NOfhcG0yn5O7CZqPVW4Rn4YWy5AuQ2_-YfZVYBVo3B3tS-h4WBxXq1_2ZCtPRp-tP_3XRSdfpqcnAW-qkCgcMvIfg-SZKUMl1LGVKEeaFwyrVDLjJXalDSLKpqVKosSE2UiFpobqkOljTIhjW2_d2CbWbCLAWznw4v8a49gG4zxiHnC4NTFOQtD5w5iFqBUjE8yS2wcdjhXqr5a1ka-XyVxE6FwL0vimy7ypofo3N7pw_9twB7BA0-wybGziMewVTVPYD93Ct3rAzLZHDhrD8g-yTfa3eun8HuESVRkakj9s8-sR-hii6XKZOafXtXf6x9oMMQnuBHZaFIvWiI93itNfC0jUjfEHTe1Vy41A20dm79gJRui7RtP5FLJZ_D5VobmOQyaaVO9AMJLy1QZM9rya5aUVGShTKXtSBuhrTntAO1BUcycEEmBARziqPiLo6LDUeFwtAO7PTIKPzO1xQYWL_99-w3cO5tcjIrRcHz-Cu5Hlsx1KXJ8FwaL-bLag7tqtajb-WtvBAS-3TaMrgEVNUZy |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Level+of+implementation+of+the+pharmacovigilance+program+and+its+associated+factors+in+health+institutions+in+Valle+del+Cauca&rft.jtitle=Revista+colombiana+de+ciencias+qu%C3%ADmico-farmac%C3%A9uticas&rft.au=Jobany+Castro+Espinosa&rft.au=Cabrera%2C+Hern%C3%A1n+Estupi%C3%B1%C3%A1n&rft.au=Gil+Pineda%2C+Mar%C3%ADa+Alejandra&rft.au=Moreno+Posso%2C+Laura+Valentina&rft.date=2024-06-06&rft.pub=Universidad+Nacional+de+Colombia&rft.issn=0034-7418&rft.eissn=1909-6356&rft.volume=53&rft.issue=2&rft.spage=488&rft_id=info:doi/10.15446%2Frcciquifa.v53n2.114453 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0034-7418&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0034-7418&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0034-7418&client=summon |